Maravai LifeSciences Holdings Inc (NAS:MRVI)
$ 5.92 0.3 (5.34%) Market Cap: 839.71 Mil Enterprise Value: 780.08 Mil PE Ratio: 0 PB Ratio: 2.43 GF Score: 74/100

Maravai LifeSciences Holdings Inc at Goldman Sachs Global Healthcare Conference Transcript

Jun 14, 2022 / 09:40PM GMT
Release Date Price: $26.33 (+1.07%)
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst

I'm Matt Sykes, the Life Science Tools and Diagnostics analyst at Goldman Sachs, and the pleasure of welcoming Maravai Life Sciences here this afternoon. Kevin Herde, the Executive Vice President and CFO. Kevin, thank you very much for joining us today.

Kevin M. Herde
Maravai LifeSciences Holdings, Inc. - Executive VP & CFO

Great. Thanks, Matt.

Questions & Answers

Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst

Maybe you could just set the stage and talk a little bit about the most recent quarter. Your guidance for the year and kind of how you see trends in the bioprocessing market evolving longer term? And we can get more into that last part, but sort of some of the highlights from the quarter and then what do you expect for the year?

Kevin M. Herde
Maravai LifeSciences Holdings, Inc. - Executive VP & CFO

Yes, certainly

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot